Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 16, 2022 Filed Mar 18, 2022 21:58 UTC |
McGaugh MichaelDirector · President and CEO
|
Exercise / conversionCommon Stock | 5,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-020092 · doc4.xml · nonDerivative · entry 4 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,270 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 21:58 UTC |
McGaugh MichaelDirector · President and CEO
|
PurchaseCommon Stock | 2,500 | $18.82 | $47,044.25 |
DisclosureSEC source: 0001209191-22-020092 · doc4.xml · nonDerivative · entry 3 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,331 Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 21:58 UTC |
McGaugh MichaelDirector · President and CEO
|
PurchaseCommon Stock | 1,300 | $18.69 | $24,296.87 |
DisclosureSEC source: 0001209191-22-020092 · doc4.xml · nonDerivative · entry 2 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,831 Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 21:58 UTC |
McGaugh MichaelDirector · President and CEO
|
PurchaseCommon Stock | 1,200 | $18.66 | $22,386.00 |
DisclosureSEC source: 0001209191-22-020092 · doc4.xml · nonDerivative · entry 1 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,531 Read SEC document |
| March 15, 2022 Filed Mar 15, 2022 23:49 UTC |
COFFIN SARAH RDirector
|
PurchaseCommon Stock | 500 | $18.37 | $9,185.00 |
DisclosureSEC source: 0001209191-22-018992 · doc4.xml · nonDerivative · entry 1 COFFIN SARAH R · CIK 0001248033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,902 Read SEC document |
| March 15, 2022 Filed Mar 15, 2022 21:10 UTC |
LIEBAU FREDERIC JACK JRDirector
|
PurchaseCommon Stock | 5,000 | $18.42 | $92,092.00 |
DisclosureSEC source: 0001209191-22-018880 · doc4.xml · nonDerivative · entry 1 LIEBAU FREDERIC JACK JR · CIK 0001424368 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,055 Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 22:03 UTC |
LISMAN BRUCE MDirector
|
PurchaseCommon Stock | 1,000 | $18.32 | $18,320.00 |
DisclosureSEC source: 0001209191-22-019290 · doc4.xml · nonDerivative · entry 1 LISMAN BRUCE M · CIK 0001280910 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,155 F1 · balance_after: On August 20, 2021, due to administrative error, the reporting person filed a Form 4 reporting that the reporting person directly owned 41,555 shares of common stock. In fact, the reporting person directly owned 41,155 shares of common stock. The overstatement in the Form 4 was also included in one subsequent Form 4 filed on November 18, 2021. Read SEC document |
| March 15, 2022 Filed Mar 18, 2022 00:46 UTC |
DEFEO RONALD MDirector
|
PurchaseCommon Stock | 10,000 | $18.49 | $184,900.00 |
DisclosureSEC source: 0001209191-22-019872 · doc4.xml · nonDerivative · entry 1 DEFEO RONALD M · CIK 0001140109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,873 F1 · price: The price reported in this column reflects the weighted average purchase price of multiple trades executed through a broker-dealer at prices ranging from $18.31-$18.62. Upon request, the reporting person will provide to the SEC staff, the Issuer, or any security holder of the issuer, detailed information regarding the number of shares sold at each price. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:53 UTC |
Robinson Sonal P.Executive Vice President, CFO
|
GrantPerformance Stock Units · Derivative | 13,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019634 · doc4.xml · derivative · entry 2 Robinson Sonal P. · CIK 0001844604 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,013 Underlying: Common Stock · 13,013 shares Expires 2025-03-16 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2024. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2024. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:53 UTC |
Robinson Sonal P.Executive Vice President, CFO
|
GrantRestricted Stock Units · Derivative | 8,676 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019634 · doc4.xml · derivative · entry 1 Robinson Sonal P. · CIK 0001844604 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,676 Underlying: Common Stock · 8,676 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: On March 15, 2022, the reporting person was granted 8,676 restricted stock units, vesting in three equal annual installments on March 16, 2023, March 16, 2024, and March 16, 2025. F2 · derivative.expiration_date: On March 15, 2022, the reporting person was granted 8,676 restricted stock units, vesting in three equal annual installments on March 16, 2023, March 16, 2024, and March 16, 2025. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:50 UTC |
McGaugh MichaelDirector · President and CEO
|
GrantPerformance Stock Units · Derivative | 84,723 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019627 · doc4.xml · derivative · entry 2 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,723 Underlying: Common Stock · 84,723 shares Expires 2025-03-16 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2024. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2024. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:50 UTC |
McGaugh MichaelDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 28,241 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019627 · doc4.xml · derivative · entry 1 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,241 Underlying: Common Stock · 28,241 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: On March 15, 2022, the reporting person was granted 28,241 restricted stock units, vesting in three equal annual installments on March 16, 2023, March 16, 2024, and March 16, 2025. F2 · derivative.expiration_date: On March 15, 2022, the reporting person was granted 28,241 restricted stock units, vesting in three equal annual installments on March 16, 2023, March 16, 2024, and March 16, 2025. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:47 UTC |
Johnson Paul AllanVP, Distribution Segment
|
GrantPerformance Stock Units · Derivative | 8,224 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019625 · doc4.xml · derivative · entry 2 Johnson Paul Allan · CIK 0001908452 · VP, Distribution Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,224 Underlying: Common Stock · 8,224 shares Expires 2025-03-16 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2024. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2024. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:47 UTC |
Johnson Paul AllanVP, Distribution Segment
|
GrantRestricted Stock Units · Derivative | 5,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019625 · doc4.xml · derivative · entry 1 Johnson Paul Allan · CIK 0001908452 · VP, Distribution Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,483 Underlying: Common Stock · 5,483 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: On March 15, 2022, the reporting person was granted 5,483 restricted stock units, vesting in three equal annual installments on March 16, 2023, March 16, 2024, and March 16, 2025. F2 · derivative.expiration_date: On March 15, 2022, the reporting person was granted 5,483 restricted stock units, vesting in three equal annual installments on March 16, 2023, March 16, 2024, and March 16, 2025. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:44 UTC |
Gurnee JimVP Sales/Marketing/Commercial
|
GrantPerformance Stock Units · Derivative | 7,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019619 · doc4.xml · derivative · entry 2 Gurnee Jim · CIK 0001905147 · VP Sales/Marketing/Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,388 Underlying: Common Stock · 7,388 shares Expires 2025-03-16 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2024. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2024. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:44 UTC |
Gurnee JimVP Sales/Marketing/Commercial
|
GrantRestricted Stock Units · Derivative | 4,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019619 · doc4.xml · derivative · entry 1 Gurnee Jim · CIK 0001905147 · VP Sales/Marketing/Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,925 Underlying: Common Stock · 4,925 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: On March 15, 2022, the reporting person was granted 4,925 restricted stock units, vesting in three equal annual installments on March 16, 2023, March 16, 2024, and March 16, 2025. F2 · derivative.expiration_date: On March 15, 2022, the reporting person was granted 4,925 restricted stock units, vesting in three equal annual installments on March 16, 2023, March 16, 2024, and March 16, 2025. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:40 UTC |
Baker Jeffrey JonVP, Shared Services
|
GrantPerformance Stock Units · Derivative | 9,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019615 · doc4.xml · derivative · entry 2 Baker Jeffrey Jon · CIK 0001908869 · VP, Shared Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,218 Underlying: Common Stock · 9,218 shares Expires 2025-03-16 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2024. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2024. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:40 UTC |
Baker Jeffrey JonVP, Shared Services
|
GrantRestricted Stock Units · Derivative | 6,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019615 · doc4.xml · derivative · entry 1 Baker Jeffrey Jon · CIK 0001908869 · VP, Shared Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,145 Underlying: Common Stock · 6,145 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: On March 15, 2022, the reporting person was granted 6,145 restricted stock units, vesting in three equal annual installments on March 16, 2023, March 16, 2024, and March 16, 2025. F2 · derivative.expiration_date: On March 15, 2022, the reporting person was granted 6,145 restricted stock units, vesting in three equal annual installments on March 16, 2023, March 16, 2024, and March 16, 2025. Read SEC document |
| March 06, 2022 Filed Mar 8, 2022 21:59 UTC |
McGaugh MichaelDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 14,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017151 · doc4.xml · derivative · entry 3 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,594 Underlying: Common Stock · 14,595 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: On April 28, 2020, the reporting person was granted 43,783 restricted stock units, vesting in three equal annual installments on March 6, 2021, March 6, 2022, and March 6, 2023. F4 · derivative.expiration_date: On April 28, 2020, the reporting person was granted 43,783 restricted stock units, vesting in three equal annual installments on March 6, 2021, March 6, 2022, and March 6, 2023. Read SEC document |
| March 06, 2022 Filed Mar 8, 2022 21:59 UTC |
McGaugh MichaelDirector · President and CEO
|
Tax withholdingCommon Stock | 4,725 | $16.60 | $78,435.00 |
DisclosureSEC source: 0001209191-22-017151 · doc4.xml · nonDerivative · entry 2 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,331 F2 · balance_after: Includes 250 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021. Read SEC document |
| March 06, 2022 Filed Mar 8, 2022 21:59 UTC |
McGaugh MichaelDirector · President and CEO
|
Exercise / conversionCommon Stock | 14,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017151 · doc4.xml · nonDerivative · entry 1 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. F2 · balance_after: Includes 250 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021. Read SEC document |
| March 06, 2022 Filed Mar 9, 2023 00:35 UTC |
McGaugh MichaelDirector · President and CEO
|
Tax withholdingCommon Stock | 5,019 | $20.71 | $103,943.49 |
DisclosureSEC source: 0001209191-23-017341 · doc4.xml · nonDerivative · entry 2 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,997 F3 · balance_after: Includes 250 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021. Read SEC document |
| March 06, 2022 Filed Mar 9, 2023 00:35 UTC |
McGaugh MichaelDirector · President and CEO
|
Exercise / conversionCommon Stock | 14,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017341 · doc4.xml · nonDerivative · entry 1 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. F2 · balance_after: Includes 1,000 shares acquired under the Issuer's employee stock purchase plan in 2022. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 22:00 UTC |
LISMAN BRUCE MDirector
|
PurchaseCommon Stock | 1,000 | $20.79 | $20,790.00 |
DisclosureSEC source: 0001209191-21-065515 · doc4.xml · nonDerivative · entry 1 LISMAN BRUCE M · CIK 0001280910 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,555 Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 21:49 UTC |
McGaugh MichaelDirector · President and CEO
|
PurchaseCommon Stock | 5,000 | $20.59 | $102,950.00 |
DisclosureSEC source: 0001209191-21-063876 · doc4.xml · nonDerivative · entry 1 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,211 F1 · price: The price reported in this column reflects the weighted average purchase price of multiple trades executed through a broker-dealer at prices ranging from $20.59-$20.62. Upon request, the reporting person will provide to the SEC staff, the Issuer, or any security holder of the issuer, detailed information regarding the number of shares sold at each price. F2 · balance_after: Includes 250 shares acquired under the Issuer's employee stock purchase plan on September 30, 2021. Read SEC document |
| August 25, 2021 Filed Aug 27, 2021 21:00 UTC |
FOLEY WILLIAM ADirector
|
PurchaseCommon stock | 1,100 | $22.85 | $25,130.49 |
DisclosureSEC source: 0001209191-21-053643 · doc4.xml · nonDerivative · entry 1 FOLEY WILLIAM A · CIK 0001215225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,493 F1 · price: The price reported in this column reflects the weighted average purchase price of multiple trades executed through a broker-dealer at prices ranging from $22.82-$22.88. Upon request, the reporting person will provide to the SEC staff, the issuer, or any security holder of the issuer, detailed information regarding the number of shares sold at each price. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 21:00 UTC |
LISMAN BRUCE MDirector
|
PurchaseCommon Stock | 500 | $22.09 | $11,045.00 |
DisclosureSEC source: 0001209191-21-052793 · doc4.xml · nonDerivative · entry 1 LISMAN BRUCE M · CIK 0001280910 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,555 Read SEC document |
| August 13, 2021 Filed Aug 16, 2021 21:10 UTC |
McGaugh MichaelDirector · President and CEO
|
PurchaseCommon Stock | 6,392 | $21.97 | $140,432.24 |
DisclosureSEC source: 0001209191-21-051645 · doc4.xml · nonDerivative · entry 2 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,961 Read SEC document |
| August 13, 2021 Filed Aug 16, 2021 21:10 UTC |
McGaugh MichaelDirector · President and CEO
|
PurchaseCommon Stock | 1,608 | $21.98 | $35,343.84 |
DisclosureSEC source: 0001209191-21-051645 · doc4.xml · nonDerivative · entry 1 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,569 Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 20:18 UTC |
McGaugh MichaelDirector · President and CEO
|
PurchaseCommon Stock | 2,500 | $21.62 | $54,049.50 |
DisclosureSEC source: 0001209191-21-050834 · doc4.xml · nonDerivative · entry 1 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,961 Read SEC document |
| May 17, 2021 Filed May 18, 2021 21:01 UTC |
McGaugh MichaelDirector · President and CEO
|
PurchaseCommon Stock | 1,000 | $21.62 | $21,620.00 |
DisclosureSEC source: 0001209191-21-033575 · doc4.xml · nonDerivative · entry 2 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,461 Read SEC document |
| May 14, 2021 Filed May 18, 2021 21:01 UTC |
McGaugh MichaelDirector · President and CEO
|
PurchaseCommon Stock | 1,500 | $21.28 | $31,912.50 |
DisclosureSEC source: 0001209191-21-033575 · doc4.xml · nonDerivative · entry 1 McGaugh Michael · CIK 0001698604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,461 Read SEC document |
| April 29, 2021 Filed May 4, 2021 00:44 UTC |
Bright Yvette DapremontDirector
|
GrantCommon Stock | 4,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029648 · doc4.xml · nonDerivative · entry 1 Bright Yvette Dapremont · CIK 0001847276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,023 F1 · kind: On April 29, 2021, the reporting person was awarded 4,023 restricted stock units with respect to the reporting person's service as a director of the Issuer on that date until the 2022 Annual Meeting of Shareholders, at which time the reporting person's award will vest, conditioned on the reporting person's continued service through the vesting date. Read SEC document |
| April 29, 2021 Filed May 4, 2021 00:47 UTC |
LISMAN BRUCE MDirector
|
GrantCommon Stock | 4,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029649 · doc4.xml · nonDerivative · entry 1 LISMAN BRUCE M · CIK 0001280910 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,655 F1 · kind: On April 29, 2021, the reporting person was awarded 4,023 restricted stock units with respect to the reporting person's service as a director of the Issuer on that date until the 2022 Annual Meeting of Shareholders, at which time the reporting person's award will vest, conditioned on the reporting person's continued service through the vesting date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 22:19 UTC |
STEFANKO ROBERT ADirector
|
GrantCommon Stock | 4,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029615 · doc4.xml · nonDerivative · entry 1 STEFANKO ROBERT A · CIK 0001200116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,617 F1 · kind: On April 29, 2021, the reporting person was awarded 4,023 restricted stock units with respect to the reporting person's service as a director of the Issuer on that date until the 2022 Annual Meeting of Shareholders, at which time the reporting person's award will vest, conditioned on the reporting person's continued service through the vesting date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 22:18 UTC |
COFFIN SARAH RDirector
|
GrantCommon Stock | 4,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029613 · doc4.xml · nonDerivative · entry 1 COFFIN SARAH R · CIK 0001248033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,402 F1 · kind: On April 29, 2021, the reporting person was awarded 4,023 restricted stock units with respect to the reporting person's service as a director of the Issuer on that date until the 2022 Annual Meeting of Shareholders, at which time the reporting person's award will vest, conditioned on the reporting person's continued service through the vesting date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 22:16 UTC |
Lutey Lori A.Director
|
GrantCommon Stock | 4,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029610 · doc4.xml · nonDerivative · entry 1 Lutey Lori A. · CIK 0001699873 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,140 F1 · kind: On April 29, 2021, the reporting person was awarded 4,023 restricted stock units with respect to the reporting person's service as a director of the Issuer on that date until the 2022 Annual Meeting of Shareholders, at which time the reporting person's award will vest, conditioned on the reporting person's continued service through the vesting date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 22:13 UTC |
LIEBAU FREDERIC JACK JRDirector
|
GrantCommon Stock | 4,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029609 · doc4.xml · nonDerivative · entry 1 LIEBAU FREDERIC JACK JR · CIK 0001424368 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,055 F1 · kind: On April 29, 2021, the reporting person was awarded 4,023 restricted stock units with respect to the reporting person's service as a director of the Issuer on that date until the 2022 Annual Meeting of Shareholders, at which time the reporting person's award will vest, conditioned on the reporting person's continued service through the vesting date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 22:11 UTC |
Kramer JeffreyDirector
|
GrantCommon Stock | 4,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029608 · doc4.xml · nonDerivative · entry 1 Kramer Jeffrey · CIK 0001704563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,023 F1 · kind: On April 29, 2021, the reporting person was awarded 4,023 restricted stock units with respect to the reporting person's service as a director of the Issuer on that date until the 2022 Annual Meeting of Shareholders, at which time the reporting person's award will vest, conditioned on the reporting person's continued service through the vesting date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 22:10 UTC |
FOLEY WILLIAM ADirector
|
GrantCommon Stock | 4,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029605 · doc4.xml · nonDerivative · entry 1 FOLEY WILLIAM A · CIK 0001215225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,393 F1 · kind: On April 29, 2021, the reporting person was awarded 4,023 restricted stock units with respect to the reporting person's service as a director of the Issuer on that date until the 2022 Annual Meeting of Shareholders, at which time the reporting person's award will vest, conditioned on the reporting person's continued service through the vesting date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 22:08 UTC |
DEFEO RONALD MDirector
|
GrantCommon Stock | 4,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029604 · doc4.xml · nonDerivative · entry 1 DEFEO RONALD M · CIK 0001140109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,873 F1 · kind: On April 29, 2021, the reporting person was awarded 4,023 restricted stock units with respect to the reporting person's service as a director of the Issuer on that date until the 2022 Annual Meeting of Shareholders, at which time the reporting person's award will vest, conditioned on the reporting person's continued service through the vesting date. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 20:54 UTC |
COFFIN SARAH RDirector
|
PurchaseCommon Stock | 1,000 | $19.53 | $19,525.00 |
DisclosureSEC source: 0001209191-21-021783 · doc4.xml · nonDerivative · entry 1 COFFIN SARAH R · CIK 0001248033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,379 Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 21:38 UTC |
Kramer JeffreyDirector
|
PurchaseCommon Stock | 10,000 | $19.82 | $198,200.00 |
DisclosureSEC source: 0001209191-21-021454 · doc4.xml · nonDerivative · entry 1 Kramer Jeffrey · CIK 0001704563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 21:32 UTC |
DEFEO RONALD MDirector
|
PurchaseCommon Stock | 10,000 | $19.80 | $198,000.00 |
DisclosureSEC source: 0001209191-21-021449 · doc4.xml · nonDerivative · entry 1 DEFEO RONALD M · CIK 0001140109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,850 Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 21:00 UTC |
Robinson Sonal P.Executive Vice President, CFO
|
GrantPerformance Stock Units · Derivative | 11,798 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-021799 · doc4.xml · derivative · entry 2 Robinson Sonal P. · CIK 0001844604 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,798 Underlying: Common Stock · 11,798 shares Expires 2024-03-16 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2023. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2023. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 21:00 UTC |
Robinson Sonal P.Executive Vice President, CFO
|
GrantRestricted Stock Units · Derivative | 7,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-021799 · doc4.xml · derivative · entry 1 Robinson Sonal P. · CIK 0001844604 · Executive Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,865 Underlying: Common Stock · 7,865 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: On March 16, 2021, the reporting person was granted 7,865 restricted stock units, vesting in three equal annual installments on March 16, 2022, March 16, 2023, and March 16, 2024. F2 · derivative.expiration_date: On March 16, 2021, the reporting person was granted 7,865 restricted stock units, vesting in three equal annual installments on March 16, 2022, March 16, 2023, and March 16, 2024. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 20:58 UTC |
Harmon Thomas P.SVP Human Resources
|
GrantPerformance Stock Units · Derivative | 6,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-021789 · doc4.xml · derivative · entry 2 Harmon Thomas P. · CIK 0001790289 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,793 Underlying: Common Stock · 6,793 shares Expires 2024-03-16 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2023. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2023. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 20:58 UTC |
Harmon Thomas P.SVP Human Resources
|
GrantRestricted Stock Units · Derivative | 4,529 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-021789 · doc4.xml · derivative · entry 1 Harmon Thomas P. · CIK 0001790289 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,529 Underlying: Common Stock · 4,529 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: On March 16, 2021, the reporting person was granted 6,793 restricted stock units, vesting in three equal annual installments on March 16, 2022, March 16, 2023, and March 16, 2024. F2 · derivative.expiration_date: On March 16, 2021, the reporting person was granted 6,793 restricted stock units, vesting in three equal annual installments on March 16, 2022, March 16, 2023, and March 16, 2024. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 20:56 UTC |
Horton AndreanEVP, CLO and Secretary
|
GrantPerformance Stock Units · Derivative | 11,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-021785 · doc4.xml · derivative · entry 2 Horton Andrean · CIK 0001661135 · EVP, CLO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,988 Underlying: Common Stock · 11,988 shares Expires 2024-03-16 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2023. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock based upon the Issuer's cumulative adjusted EBITDA with a relative TSR modifier over a three-year performance period ending December 31, 2023. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 20:56 UTC |
Horton AndreanEVP, CLO and Secretary
|
GrantRestricted Stock Units · Derivative | 7,992 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-021785 · doc4.xml · derivative · entry 1 Horton Andrean · CIK 0001661135 · EVP, CLO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,992 Underlying: Common Stock · 7,992 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: On March 16, 2021, the reporting person was granted 7,992 restricted stock units, vesting in three equal annual installments on March 16, 2022, March 16, 2023, and March 16, 2024. F2 · derivative.expiration_date: On March 16, 2021, the reporting person was granted 7,992 restricted stock units, vesting in three equal annual installments on March 16, 2022, March 16, 2023, and March 16, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.